CLOVER HEALTH INVESTMENTS, CORP. /DE vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CLOV and OSCR diverge most: on net margin, CLOV reads -0.7% and OSCR reads 3.6%; on return on equity, CLOV reads -4.9% and OSCR reads 26.8%. The rest of the comparable metrics sit closer together. The bull and bear cases for each are in their full reports below.
| Metric | CLOV | OSCR |
|---|---|---|
| Price | $4.80 | $33.37 |
| Market cap | $2.6B | $11.1B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/E | — | 23.0 |
| P/B | 6.96 | 5.41 |
| P/S | 1.06 | 0.73 |
| EV/EBITDA | 55.9 | 11.4 |
| Revenue growth | +53.1% | +40.9% |
| Operating margin | 3.8% | 8.0% |
| Net margin | -0.7% | 3.6% |
| Return on equity | -4.9% | 26.8% |
| Return on assets | -2.5% | 4.9% |
| Return on invested capital | 8.7% | 24.7% |
| FCF yield | 2.8% | 39.4% |
| Debt / equity | 0.00 | 0.21 |
| Current ratio | 1.50 | 1.08 |
| Altman Z (solvency) | 4.06 | 2.00 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.